Kureha Corporation   Report issue

For profit Phase 4
Founded: Tokyo Japan (1944)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2007
NCT00501046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now